# Preventing Alcohol Withdrawal Syndrome With Oral Baclofen

> **NCT02052440** · PHASE3 · TERMINATED · sponsor: **Denver Health and Hospital Authority** · enrollment: 102 (actual)

## Conditions studied

- Alcohol Withdrawal Syndrome

## Interventions

- **DRUG:** Baclofen
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02052440
- **Lead sponsor:** Denver Health and Hospital Authority
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-03-15
- **Primary completion:** 2017-01-01
- **Final completion:** 2017-01-01
- **Target enrollment:** 102 (ACTUAL)
- **Why stopped:** Insufficient funding to complete with low enrollment rate
- **Last updated:** 2018-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02052440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02052440, "Preventing Alcohol Withdrawal Syndrome With Oral Baclofen". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02052440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*